đź“‹ FDA Reference
dermagran hydrophilic ointment
Derma Sciences
Summary: Dermagran Hydrophilic Ointment is a topical ointment used for wound care. It is primarily used by healthcare professionals in dermatology and wound management to promote healing in various types of wounds.
FDA Clearance Information
Pathway
510K
Number
K963603 ↗
Decision Date
November 27, 1996
Product Code
KMF
Device Class
Class 1
Evidence
419 studies
Dermagran Hydrophilic Ointment was cleared through the FDA 510(k) pathway on November 27, 1996. Manufactured by Derma Sciences, it is classified as a Class 1 medical device.
What It Is
Dermagran Hydrophilic Ointment is a topical formulation designed to provide a moist wound environment, which is essential for optimal wound healing. It contains ingredients that support the natural healing process by maintaining hydration and protecting the wound from external contaminants. This ointment is particularly useful in managing chronic and acute wounds, including pressure ulcers, diabetic ulcers, and surgical incisions.
Clinical Applications
This ointment is commonly used in clinical settings such as hospitals, outpatient clinics, and long-term care facilities. It is particularly beneficial in dermatology and wound care specialties, where maintaining a moist wound environment is crucial for healing. Patients with chronic wounds, such as those with diabetes or limited mobility, often benefit from its application.
Indications for Use
The FDA indications suggest that Dermagran Hydrophilic Ointment is intended for use in managing wounds that require a moist environment to heal. This includes a variety of wound types such as pressure sores, diabetic ulcers, and post-surgical wounds.
Practical Considerations
Dermagran Hydrophilic Ointment is typically applied directly to the wound bed and covered with a suitable secondary dressing. It is compatible with most standard wound dressings and should be used according to the wound's condition and size. Regular monitoring and dressing changes are recommended to ensure optimal healing.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Dermagran Hydrophilic Ointment used for?
It is used to promote healing in various types of wounds by maintaining a moist environment.
What specialties typically use this device?
Dermatology and wound care specialists commonly use this ointment.
What are the FDA-cleared indications?
It is indicated for use in managing wounds that require a moist environment to heal, such as pressure sores and diabetic ulcers.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.